Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG) (English)
- New search for: Garbay, D.
- New search for: Le Cesne, A.
- New search for: Penel, N.
- New search for: Chevreau, C.
- New search for: Marec-Berard, P.
- New search for: Blay, J. Y.
- New search for: Debled, M.
- New search for: Isambert, N.
- New search for: Thyss, A.
- New search for: Bompas, E.
- New search for: Garbay, D.
- New search for: Le Cesne, A.
- New search for: Penel, N.
- New search for: Chevreau, C.
- New search for: Marec-Berard, P.
- New search for: Blay, J. Y.
- New search for: Debled, M.
- New search for: Isambert, N.
- New search for: Thyss, A.
- New search for: Bompas, E.
In:
ANNALS OF ONCOLOGY
;
23
, 1
;
182-186
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)
-
Contributors:Garbay, D. ( author ) / Le Cesne, A. ( author ) / Penel, N. ( author ) / Chevreau, C. ( author ) / Marec-Berard, P. ( author ) / Blay, J. Y. ( author ) / Debled, M. ( author ) / Isambert, N. ( author ) / Thyss, A. ( author ) / Bompas, E. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 1 ; 182-186
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:5 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Thanks to referees 2011| 2012
- 6
-
Dissecting responsive phenotypes through cytokine and angiogenic factor analysisRini, B. et al. | 2012
- 7
-
The hazards of randomized phase II trialsLara, P. N. / Redman, M. W. et al. | 2012
- 10
-
New treatment modalities in advanced thyroid cancerKapiteijn, E. / Schneider, T. C. / Morreau, H. / Gelderblom, H. / Nortier, J. W. / Smit, J. W. et al. | 2012
- 19
-
Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic reviewTraa, M. J. / De Vries, J. / Roukema, J. A. / Den Oudsten, B. L. et al. | 2012
- 28
-
A meta-analysis on alcohol drinking and gastric cancer riskTramacere, I. / Negri, E. / Pelucchi, C. / Bagnardi, V. / Rota, M. / Scotti, L. / Islami, F. / Corrao, G. / La Vecchia, C. / Boffetta, P. et al. | 2012
- 37
-
Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studiesAune, D. / Lau, R. / Chan, D. S. / Vieira, R. / Greenwood, D. C. / Kampman, E. / Norat, T. et al. | 2012
- 46
-
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinomaZurita, A. J. / Jonasch, E. / Wang, X. / Khajavi, M. / Yan, S. / Du, D. Z. / Xu, L. / Herynk, M. H. / McKee, K. S. / Tran, H. T. et al. | 2012
- 53
-
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07aChi, K. N. / Beardsley, E. / Eigl, B. J. / Venner, P. / Hotte, S. J. / Winquist, E. / Ko, Y. J. / Sridhar, S. S. / Weber, D. / Saad, F. et al. | 2012
- 59
-
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialBachner, M. / Loriot, Y. / Gross-Goupil, M. / Zucali, P. A. / Horwich, A. / Germa-Lluch, J. R. / Kollmannsberger, C. / Stoiber, F. / Flechon, A. / Oechsle, K. et al. | 2012
- 65
-
Clinically relevant fatigue in recurrence-free prostate cancer survivorsStorey, D. J. / McLaren, D. B. / Atkinson, M. A. / Butcher, I. / Liggatt, S. / O'Dea, R. / Smyth, J. F. / Sharpe, M. et al. | 2012
- 72
-
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerManegold, C. / van Zandwijk, N. / Szczesna, A. / Zatloukal, P. / Au, J. S. / Blasinska-Morawiec, M. / Serwatowski, P. / Krzakowski, M. / Jassem, J. / Tan, E. H. et al. | 2012
- 78
-
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survivalWilliam, W. N. / Kim, J. S. / Liu, D. D. / Solis, L. / Behrens, C. / Lee, J. J. / Lippman, S. M. / Kim, E. S. / Hong, W. K. / Wistuba, I. I. et al. | 2012
- 86
-
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsReiman, T. / Lai, R. / Veillard, A. S. / Paris, E. / Soria, J. C. / Rosell, R. / Taron, M. / Graziano, S. / Kratzke, R. / Seymour, L. et al. | 2012
- 93
-
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancerOlson, E. M. / Lin, N. U. / DiPiro, P. J. / Najita, J. S. / Krop, I. E. / Winer, E. P. / Burstein, H. J. et al. | 2012
- 98
-
Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?Heil, J. / Buehler, A. / Golatta, M. / Rom, J. / Schipp, A. / Harcos, A. / Schneeweiss, A. / Rauch, G. / Sohn, C. / Junkermann, H. et al. | 2012
- 104
-
Effect of protocol-related variables and womens characteristics on the cumulative false-positive risk in breast cancer screeningRoman, R. / Sala, M. / Salas, D. / Ascunce, N. / Zubizarreta, R. / Castells, X. et al. | 2012
- 111
-
First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA studyBiganzoli, L. / Di Vincenzo, E. / Jiang, Z. / Lichinitser, M. / Shen, Z. / Delva, R. / Bogdanova, N. / Vivanco, G. L. / Chen, Z. / Cheng, Y. et al. | 2012
- 119
-
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerStarling, N. / Vazquez-Mazon, F. / Cunningham, D. / Chau, I. / Tabernero, J. / Ramos, F. J. / Iveson, T. J. / Saunders, M. P. / Aranda, E. / Countouriotis, A. M. et al. | 2012
- 127
-
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primariesCorbo, V. / Beghelli, S. / Bersani, S. / Antonello, D. / Talamini, G. / Brunelli, M. / Capelli, P. / Falconi, M. / Scarpa, A. et al. | 2012
- 135
-
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancerCatalano, V. / Loupakis, F. / Graziano, F. / Bisonni, R. / Torresi, U. / Vincenzi, B. / Mari, D. / Giordani, P. / Alessandroni, P. / Salvatore, L. et al. | 2012
- 141
-
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppressionAlfa-Wali, M. / Allen-Mersh, T. / Antoniou, A. / Tait, D. / Newsom-Davis, T. / Gazzard, B. / Nelson, M. / Bower, M. et al. | 2012
- 147
-
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma GroupGang, A. O. / Strom, C. / Pedersen, M. / d'Amore, F. / Pedersen, L. M. / Bukh, A. / Pedersen, B. B. / Moeller, M. B. / Mortensen, L. S. / Gadeberg, O. V. et al. | 2012
- 153
-
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in TaiwanTseng, C. H. et al. | 2012
- 159
-
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classificationMatasar, M. J. / Shi, W. / Silberstien, J. / Lin, O. / Busam, K. J. / Teruya-Feldstein, J. / Filippa, D. A. / Zelenetz, A. D. / Noy, A. et al. | 2012
- 166
-
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)Jantunen, E. / Canals, C. / Attal, M. / Thomson, K. / Milpied, N. / Buzyn, A. / Ferrant, A. / Biron, P. / Crawley, C. / Schattenberg, A. et al. | 2012
- 171
-
Diverging trends in incidence and mortality, and improved survival of non-Hodgkins lymphoma, in the Netherlands, 1989-2007van de Schans, S. A. / Issa, D. E. / Visser, O. / Nooijen, P. / Huijgens, P. C. / Karim-Kos, H. E. / Janssen-Heijnen, M. L. / Coebergh, J. W. et al. | 2012
- 182
-
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)Garbay, D. / Le Cesne, A. / Penel, N. / Chevreau, C. / Marec-Berard, P. / Blay, J. Y. / Debled, M. / Isambert, N. / Thyss, A. / Bompas, E. et al. | 2012
- 186
-
Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinomaKawakita, D. / Matsuo, K. / Sato, F. / Oze, I. / Hosono, S. / Ito, H. / Watanabe, M. / Yatabe, Y. / Hanai, N. / Hasegawa, Y. et al. | 2012
- 193
-
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experienceVandone, A. M. / Donadio, M. / Mozzati, M. / Ardine, M. / Polimeni, M. A. / Beatrice, S. / Ciuffreda, L. / Scoletta, M. et al. | 2012
- 200
-
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialDurand, J. P. / Deplanque, G. / Montheil, V. / Gornet, J. M. / Scotte, F. / Mir, O. / Cessot, A. / Coriat, R. / Raymond, E. / Mitry, E. et al. | 2012
- 205
-
Physician, patient and family attitudes regarding information on prognosis: a Brazilian surveyFumis, R. R. / De Camargo, B. / Del Giglio, A. et al. | 2012
- 211
-
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer careBen-Arye, E. / Schiff, E. / Hassan, E. / Mutafoglu, K. / Lev-Ari, S. / Steiner, M. / Lavie, O. / Polliack, A. / Silbermann, M. / Lev, E. et al. | 2012
- 222
-
Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trialAranda, S. / Jefford, M. / Yates, P. / Gough, K. / Seymour, J. / Francis, P. / Baravelli, C. / Breen, S. / Schofield, P. et al. | 2012
- 231
-
Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neckNg, Q. S. / Mandeville, H. / Goh, V. / Alonzi, R. / Milner, J. / Carnell, D. / Meer, K. / Padhani, A. R. / Saunders, M. I. / Hoskin, P. J. et al. | 2012
- 238
-
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)Kollmannsberger, C. / Hirte, H. / Siu, L. L. / Mazurka, J. / Chi, K. / Elit, L. / Walsh, W. / Sederias, J. / Doyle, A. / Eisenhauer, E. A. et al. | 2012
- 245
-
Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later lifeQiu, L. / Low, H. P. / Chang, C. I. / Strohsnitter, W. C. / Anderson, M. / Edmiston, K. / Adami, H. O. / Ekbom, A. / Hall, P. / Lagiou, P. et al. | 2012
- 251
-
Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancerBrandt, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 256
-
Prostate cancer treatment ascertained from several sources: analysis of disagreement and errorGoodman, M. / Steenland, N. K. / Almon, M. L. / Liff, J. S. / Dilorio, C. K. / Butler, S. O. / Ekwueme, D. U. / Hall, I. J. / Smith, J. L. / Master, V. A. et al. | 2012
- 264
-
Fiber intake and pancreatic cancer risk: a case-control studyBidoli, E. / Pelucchi, C. / Zucchetto, A. / Negri, E. / Dal Maso, L. / Polesel, J. / Boz, G. / Montella, M. / Franceschi, S. / Serraino, D. et al. | 2012
- 269
-
Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?Shu, X. / Liu, H. / Ji, J. / Sundquist, K. / Forsti, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 276
-
Bevacizumab-induced laryngeal necrosisHartl, D. M. / Bahleda, R. / Hollebecque, A. / Bosq, J. / Massard, C. / Soria, J. C. et al. | 2012
- 278
-
Investigating changes over time in socioeconomic gaps in cancer survival: using differences in relative survival versus differences in excess mortality rates can give different answersBlakely, T. / Soeberg, M. / Sarfati, D. et al. | 2012
- 279
-
Reply to investigating changes over time in socioeconomic gaps in cancer survival: does choice of approach matter?Lyratzopoulos, G. / Rachet, B. / Coleman, M. P. et al. | 2012
- 280
-
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implicationsMir, O. / Coriat, R. / Boudou-Rouquette, P. / Durand, J. P. / Goldwasser, F. et al. | 2012
- 281
-
The ARCAD advanced colorectal cancer database-open for businessBuyse, M. / Sargent, D. J. / Goldberg, R. M. / de Gramont, A. et al. | 2012